A FLOW CONTROL SYSTEM OF A CARTRIDGE
An apparatus having a disposable cytometer cartridge containing pumps, pressure chambers, reservoirs, flow sensors, flow channels, and microfluidic circuits with fluid operations on the cartridge. The circuits may include mesopumps and mesovalves embedded in the chip, card or cartridge. The apparatus may have multiple detecting, analyzing and identification capabilities of blood or other fluids of interest. The sample to be tested may be entered in the disposable microfluidic cartridge which in turn is insertable in a hand-holdable or portable cytometer instrument. This apparatus may have significant application in biological warfare agent detection, water analyses, environmental checks, hematology, and other clinical and research fields.
Latest HONEYWELL INTERNATIONAL INC. Patents:
- Method and system for using a plurality of motion sensors to control a pan-tilt-zoom camera
- Controller with programmable hand-off-auto (HOA) switches
- System and method for improving air traffic communication (ATC) transcription accuracy by input of pilot run-time edits
- System and method for providing contextual feedback in response to a command
- Adjustable face mask assembly
This present application is a continuation-in-part of U.S. patent application No. 10/304,773, filed Nov. 26, 2002, which is a continuation-in-part of U.S. patent application Ser. No. 09/630,924, filed Aug. 2, 2000, now U.S. Pat. No. 6,597,438 B1, and claims the benefit thereof. Also, this present application is a continuation-in-part of U.S. patent application Ser. No. 10/980,685, filed Nov. 3, 2004, which is a division of U.S. patent application Ser. No. 10/174,851, filed Jun. 19, 2002, now U.S. Pat. No. 6,837,476, and claims the benefit thereof. Also, this present application is a continuation-in-part of U.S. patent application Ser. No. 10/340,231, filed Jan. 10, 2003, which is a division of U.S. patent application Ser. No. 09/586,093, filed Jun. 2, 2000, now U.S. Pat. No. 6,568,286 B1, and claims the benefit thereof. All of the above-mentioned patent documents are incorporated herein by reference.
The present invention is related to U.S. patent application Ser. No. 10/905,995, filed Jan. 28, 2005, by Cabuz et al., entitled “Mesovalve Modulator”, and incorporated herein by reference. Also, the present invention is related U.S. patent application Ser. No. 11/018,799, filed Dec. 21, 2004, by Cabuz et al., entitled “Media Isolated Electrostatically Actuated Valve”, and incorporated herein by reference. These applications are owned by the same entity that owns the present invention.
The present invention is also related to U.S. Pat. No. 6,549,275 B1, issued Apr. 15, 2003 to Cabuz et al., and entitled “Optical Detection System for Flow Cytometry”; U.S. Pat. No. 6,382,228 B1, issued May 7, 2002 to Cabuz et al., and entitled “Fluid Driving System for Flow Cytometry”; U.S. Pat. No. 6,700,130 B2, issued Mar. 2, 2004 to Fritz, and entitled “Optical Detection System for Flow Cytometry”; U.S. Pat. No. 6,729,856 B2, issued May 4, 2004, to Cabuz et al., and entitled “Electrostatically Actuated Pump with Elastic Restoring Forces”; U.S. Pat. No. 6,255,758 B1, issued Jul. 3, 2001, to Cabuz et al., and entitled “Polymer Microactuator Array with Macroscopic Force and Displacement”; U.S. Pat. No. 6,240,944 B1, issued June 5, 2001 to Ohnstein et al., and entitled “Addressable Valve Arrays for Proportional Pressure or Flow Control”; U.S. Pat. No. 6,179,586 B1, issued Jan. 30, 2001 to Herb et al., and entitled “Dual Diaphragm, Single Chamber Mesopump”; and U.S. Pat. No. 5,836,750, issued Nov. 17, 1998 to Cabuz, and entitled “Electrostatically Actuated Mesopump Having a Plurality of Elementary Cells”; all of which are incorporated herein by reference. These patents are owned by the same entity that owns the present invention.
BACKGROUNDThe present invention relates generally to flow cytometers. More particularly, the present invention relates to portable flow cytometers that sense optical properties of microscopic biological particles or components in a flow stream.
Flow cytometry is a technique that is used to determine certain physical and chemical properties of microscopic biological particles or components by sensing certain optical properties of the particles or components. To do so, for instance, the particles may be arranged in single file using hydrodynamic focusing within a sheath fluid. The particles are then individually interrogated by a light beam. Each particle scatters the light beam and produces a scatter profile. The scatter profile is often identified by measuring the light intensity at different scatter angles. Certain physical and/or chemical properties of each particle can then be determined from the scatter profile.
Flow cytometry is currently used in a wide variety of applications including hematology, immunology, genetics, food science, pharmacology, microbiology, parasitology, oncology, biological agent detection, and environmental science, to name a few. A limitation of many commercially available flow cytometer systems is that they are relatively large bench top instruments that must remain in a central laboratory environment. Accordingly, the use of such flow cytometers is often not available in remote locations or for continuous hematological monitoring.
SUMMARYThe present invention can overcome many of the disadvantages of the related art by providing a highly miniaturized portable and wearable apparatus (e.g., cytometer) that is usable at remote locations, such as at home or in the field. The apparatus may incorporate fluid devices and operations on a disposable cartridge, chip or card, with optical and electrical interfaces external to the cartridge. Such an apparatus may help improve healthcare of patients by providing detailed individual hematological evaluation and uncovering statistical trends. By detecting an infection early, the infection may be more readily treatable. The apparatus may also be used in non-medical applications such as those in various environmental and industrial areas.
In military applications, the apparatus may be a portable miniaturized cytometer of the present invention may help save lives by providing early detection of infection due to biological agents. It is known that expanded activity in the biological sciences has increased the probability of accidental exposure to dangerous biological agents. The ease of manufacturing such agents also raises a serious threat to their use by terrorists, regional powers or developing third world nations. The lack of safeguards in international agreements outlawing biological warfare, and compelling evidence that those agreements may have been violated, reinforces the need for a strong capability for biological defense. Pre-exposure detection of pathogen agents, as well as post-exposure detection of incipient infections may be used cooperatively to ensure efficient protection during biological warfare.
As part of the body's natural defense against antigens, the white blood cell count increases at the onset of infection. There are several types of white blood cells including neutrophils, lymphocytes, monocytes, eosinophils and basofils. Lymphocytes create antibodies that attack the invaders and mark them for destruction by the neutrophils and macrophages. In an individual without chronic diseases (such as tuberculosis or cancer), an increase in the percentage of lymphocytes in the overall white cell count is an indication of a viral infection. On the other side, an increase in the percentage of the neutrophils is an indication of a developing bacterial infection. Through counting of neutrophils and lymphocytes, a clear infection warning can be issued with differentiation between viral or bacterial causes.
The first clinical symptoms of infection from some bacterial agents such as bacillus anthrax appear after one to six days. In 99 percent of the cases, patients showing symptoms from anthrax cannot be treated, and will most likely die. However, if treatment is given before the first symptoms appear, most patients can be successfully treated. Accordingly, it would be highly desirable to provide an early alert and potential therapeutic intervention for hematologic abnormalities before symptoms occur. In many cases, such an early alert and treatment may greatly improve the outcome for many patients.
FIG. 9 is a graph showing the light intensity produced along the light source axis of
In an illustrative example of the present invention, a portable miniaturized cytometer may be provided for identifying and/or counting selected particles in a fluid sample such as a blood sample. One illustrative miniaturized portable cytometer includes a fluid receiver for receiving the fluid sample. One or more reservoirs are provided for storing supporting fluids such as lyse and sheath fluids. For many commercial flow cytometer systems, a precision fluid driving system is used for providing precise pressures to the fluids. A limitation of this approach is that precision fluid driving systems can be bulky, complex and may require significant power.
To avoid many of these limitations, an illustrative example uses a non-precision fluid driver that is controlled by a closed loop feedback path. The non-precision fluid driver is coupled to the fluid receiver and the various supporting fluid reservoirs, and applies separate pressures to the sample fluid and the supporting fluids. To control the velocity of the sample fluid and the supporting fluids, one or more valves are coupled to the fluid driver. The valves are used to regulate the non-precision pressures that are applied to the sample fluid and the supporting fluids by the non-precision fluid driver.
To complete the feedback loop, flow sensors are provided downstream of the fluid driver to measure the fluid velocity of the sample fluid and the supporting fluids. A controller or processor receives the signals from the flow sensors, and adjusts the appropriate valves so that the desired fluid velocities of the sample fluid and supporting fluids are achieved. The flow sensors are preferably thermal anemometer type flow sensors.
In one illustrative example, the non-precision fluid driver is manually powered. A manually powered fluid driver may include, for example, a bulb with check valve or a plunger. In either case, the manually generated pressure is preferably provided to a first pressure chamber. A first valve is then provided for controllably releasing the pressure in the first pressure chamber to a second pressure chamber. A second valve may be provided in the second pressure chamber for controllably venting the pressure in the second pressure chamber. The controller opens the first valve when the fluid flow in the downstream fluid stream drops below a first predetermined value and opens the second valve when the fluid flow in the downstream fluid stream increases above a second predetermined value. Each valve is preferably an array of electrostatically actuated microvalves that are individually addressable and controllable.
The controlled sample fluid and supporting fluids are provided to a fluidic circuit. The fluidic circuit may perform hydrodynamic focusing, which causes the desired particles to fall into single file along a core stream surrounded by a sheath fluid. One or more light sources or light source arrangements provide light through the flow stream, and one or more light detectors or light detector arrangements detect the scatter profile and fluorescence of the particles in the flow stream. An arrangement may have one or more light sources and/or one or more light detectors. An arrangement may include a single optical device or element or an array of such items. A processing block uses the output signals from the light detectors to identify and/or count selected particles in the core stream.
The miniaturized portable cytometer may be provided in a housing sufficiently small to be appropriately and comfortably “wearable” on a person. In one illustrative example of the invention, the housing is sized similar to a wrist watch. The wearable housing may include, for example, a base, a cover, and a hinge that secures the base to the cover. The non-precision fluid driver and regulating valves may be incorporated into the cover, while the fluid reservoirs, flow sensors and fluidic circuit may be incorporated into a removable cartridge (or “card” as it may sometimes be referred to) that is inserted into the housing. The fluidic circuit may dilute the blood sample, perform red cell lysing, and perform hydrodynamic focusing for flow and core stream formation. The light sources may be situated in either the base or the cover, and aligned with the flow stream of the removable cartridge. The light detectors are preferably provided generally opposite the light sources. The processor and batteries may be provided in either the base or the cover of the housing.
The light source may include one or a linear array of first light sources along a first light source axis. The first light source axis may be rotated relative to the central axis of the flow stream. A lens may be provided adjacent each light source to focus the light at the particles in the core stream. A detector or set of light detectors may then be placed in-line with the light source or each of the light sources. Such an arrangement can be used to determine, for example, the alignment and width of the core stream within the flow stream. If the core stream of particles is not in proper alignment, the controller can adjust the fluid velocity of the sample fluid or one of the supporting fluids to bring the core stream into alignment. The light detector or set of light detectors may also be used to detect the velocity and size of each particle, as well as the number of particles.
Another light source or set of the light sources may be provided along second light source axis. A lens may be provided adjacent each light source to focus the light at the particles in the core stream. A second detector or set of light detectors may then be placed on either side of the in-line position of each light source for measuring the small angle scattering (SALS) produced by selected particles in the flow stream.
The second light source or set of light sources may also be used in conjunction with the first set of light sources to determine the time-of-flight or velocity of the particles in the flow stream. By knowing the velocity of the particles, small variations in the flow rate caused by the fluid driver can be minimized or removed by the controller.
A third light source or set of light sources may be provided along a third light source axis. A lens may be provided adjacent each light source to provide collimated light to the flow stream. An annular light detector or detectors may then be placed opposite the light source or light sources for measuring the forward angle scattering (FALS) produced by the selected particles in the flow stream. Each of the first, second and third light sources or sets of light sources may include an array of lasers such as vertical cavity surface emitting lasers (VCSELs) fabricated on a common substrate. Each of the first, second and third detectors or sets of light detectors may include a photo detector or an array of photo detectors such as p-i-n photodiodes, GaAs photodiodes with integrated FET circuits, resonant cavity photo detectors (RCPDs), or any other suitable light detectors.
The selected particles are preferably neutrophils and/or lymphocytes white blood cells. By examining the scatter profile of each particle, the miniaturized portable cytometer of the present invention identifies and counts the neutrophils and lymphocytes in a blood sample, and provides a clear infection warning with differentiation between viral and bacterial causes.
Another part of the invention uses of fluorescence to further identify and analyze various white cells. Antibodies may be associated with particular white blood cells. The antibodies have markers or tags attached to them. These white blood cells may be impinged with light which causes their associated markers or tags to fluoresce and emit light. The light may be collected, filtered as needed, and directed to one or more photo detectors. This detection may be used to identify and monitor specific subclasses of white cells and blood-based proteins, among other things.
This miniaturized portable cytometer may have two optical detection subsystems—scattering and fluorescing. It also has a low power electronic system, a compact fluid driving system, and may use direct/unprocessed blood samples and disposable microfluidic cartridges,
The removable cartridge 14 preferably receives a sample fluid via a sample collector port 32. A cap 38 may be used to protect the sample collector port 32 when the removable cartridge 14 is not in use. The removable cartridge 14 may perform blood dilution, red cell lysing, and hydrodynamic focusing for core formation. The removable cartridge 14 may be constructed similar to the fluidic circuits available from Micronics Technologies, some of which are fabricated using a laminated structure with etched channels.
The removable structure or cartridge 14 is inserted into the housing when the cover 18 is in the open position. The removable cartridge 14 may include holes 26a and 26b for receiving registration pins 28a and 28b in the base 16, which help provide alignment and coupling between the different parts of the instrument. The removable cartridge 14 also preferably includes transparent flow stream windows 30a and 30b, which are in alignment with the arrays of the light sources 22a and 22b, and light detectors 24a and 24b. When the cover is moved to the closed position, and the system is pressurized, the cover 18 provides controlled pressures to pressure receiving ports 34a, 34b, and 34c in the removable cartridge 14 via pressure providing ports 36a, 36b and 36c, respectively.
To initiate a test, the cover 18 is lifted and a new cartridge 14 is placed and registered onto the base 16. A blood sample is introduced into the sample collector 32. The cover 18 is closed and the system is manually pressurized. Once pressurized, the instrument performs a white blood cell cytometry measurement. The removable cartridge 14 may provide blood dilution, red cell lysing, and hydrodynamic focusing for core formation. The light sources 22a and 22b, light detectors 24a and 24b and associated control and processing electronics may perform differentiation and counting of white blood cells based on light scattering fluorescent signals. Rather than using a hinged construction for the housing 12, it is contemplated that a sliding cartridge slot or any other suitable construction may be used.
The removable cartridge 14 may receive a sample fluid via the sample collector port 32. When pressurized by the cover 18, the removable cartridge 14 may perform blood dilution, red cell lysing, and hydrodynamic focusing for core formation in the present device. Once formed, the core may be provided down a flow stream path 50, which passes the flow stream windows 30a and 30b of
It is contemplated that the removable cartridge 14 may include a fluid control block 48 for helping control the velocity of each of the fluids. In the illustrative example, the fluid control block 48 includes flow sensors for sensing the velocity of the various fluids and reports the velocities to the controller or processor 40. The controller or processor 40 may then adjust the microvalves associated with pressure-chambers 46a, 46b and 46c to achieve the desired pressures and thus desired fluid velocities for proper operation of the cytometer.
Because blood and other biological waste can spread disease, the removable cartridge 14 preferably has a waste reservoir 52 downstream of the flow stream windows 30a and 30b. The waste reservoir 52 receives and stores the fluid of the flow stream in the removable cartridge 14. When a test is completed, the removable cartridge may be removed and disposed of, preferably in a container compatible with biological waste.
There are three pressure chambers 46a, 46b and 46c, one for each fluid to be pressurized. In the illustrative example, pressure chamber 46a provides pressure to a blood sample reservoir 62, pressure chamber 46b provides pressure to a lyse reservoir 64, and pressure chamber 46c provides pressure to a sheath reservoir 66. The size and shape of each pressure chamber 46a, 46b and 46c may be tailored to provide the desired pressure characteristics to the corresponding fluid.
Pressure chamber 46a includes a first pressure chamber 70 and a second pressure chamber 72. A first valve 74 is provided between the first pressure chamber 70 and the second pressure chamber 72 for controllably releasing the pressure in the first pressure chamber 70 to a second pressure chamber 72. A second valve 76, in fluid communication with the second pressure chamber 72, controllably vents the pressure in the second pressure chamber 72. Each valve is preferably an array of electrostatically actuated microvalves that are individually addressable and controllable, as described in, for example, co-pending U.S. patent application Ser. No. 09/404,560, entitled “Addressable Valve Arrays for Proportional Pressure or Flow Control”, and incorporated herein by reference. Pressure chambers 46b and 46c include similar valves to control the pressures applied to the lyse reservoir 64 and sheath reservoir 66, respectively. Alternatively, each valve may be an array of electrostatically actuated microvalves that are pulse modulated with a controllable duty cycle to achieve a controlled “effective” flow or leak rate.
The removable cartridge 14 has pressure receiving ports 34a, 34b, and 34c for receiving the controlled pressures from the cover 18. The controlled pressures are provided to the blood reservoir 62, lyse reservoir 64 and sheath reservoir 66, as shown. The lyse reservoir 64 and sheath reservoir 66 are preferably filled before the removable cartridge 14 is shipped for use, while the blood reservoir 62 is filled from sample collector port 32. A blood sample may be provided to the sample collector port 32, and through capillary action, the blood sample is sucked into the blood reservoir 62. Once the blood sample is in the blood reservoir 62, the cover 18 may be closed and the system may be pressurized.
A flow sensor may be provided in-line with each fluid prior to hydrodynamic focusing. Each flow sensor 80, 100 and 102 may measure the velocity of the corresponding fluid. The flow sensors may be thermal anemometer type flow sensors and/or microbridge type flow sensor. Microbridge flow sensors are described in, for example, U.S. Pat. No. 4,478,076, U.S. Pat. No. 4,478,077, U.S. Pat. No. 4,501,144, U.S. Pat. No. 4,651,564, U.S. Pat. No. 4,683,159, and U.S. Pat. No. 5,050,429, all of which are incorporated herein by reference. An output signal from each flow sensor 80, 100 and 102 is provided to controller or processor 40.
The controller or processor 40 opens the first valve 74 when the velocity of the blood sample drops below a first predetermined value and opens the second valve 76 when Page 15 of 78 the velocity of the blood sample increases above a second predetermined value. Valves 84, 86, 94 and 96 operate in a similar manner to control the velocities of the lyse and sheath fluids.
During operation, and to pressurize the system, the manual pressurizing element 44 is depressed. In the example shown, the manual pressurizing element 44 includes three plungers, with each plunger received within a corresponding one of the first pressure chambers. The plungers create a relatively high non-precision pressure in the first pressure chambers. Lower, controlled pressures are built in the secondary chambers by opening the first valves 70, 84 and 94, which produce a controllable leak into the secondary chambers. If too much pressure builds up in the secondary pressure chambers, the corresponding vent valves 76, 86 and 96 are opened to relieve the pressure.
When closing the cover 18, the normally open first valves 74, 84 and 94 are closed while the vent valves 76, 86 and 96 are open. When a predetermined pressure P is achieved in the first pressure chambers, the vent valves 76, 86 and 96 are closed, and the first valves 74, 84 and 94 are opened to build a lower pressure P′ in the secondary pressure chambers. The controlled pressure in the secondary pressure chambers provide the necessary pressures to the fluidic circuit of the removable cartridge 14 to produce fluid flow for the blood, lyse and sheath. The velocity of the fluid flow is then measured by the downstream flow sensors 80, 100 and 102. Each flow sensor provides an output signal that is used by the controller or processor 40 to control the operation of the corresponding first valve and vent valve to provide a desired and constant flow rate for each fluid.
Downstream valves generally shown at 110 may also be provided. Controller or processor 40 may close downstream valves 110 until the system is pressurized. This may help prevent the blood, lyse and sheath from flowing into the fluid circuit before the circuit is pressurized. In another illustrative example of the invention, downstream valves 110 are opened by mechanical action when the cover is closed.
Rather than using a manually operated fluid driver, it is contemplated that any relatively small pressure source may be used including, for example, an electrostatically actuated mesopump. One such mesopump is described in, for example, U.S. Pat. No. 5,836,750 to Cabuz, which is incorporated herein by reference.
Light emitters 22a and 22b, and associated optics are preferably provided adjacent one side of the flow stream 50. Light detectors 24a and 24b, and associated optics are provided on another side of the flow stream 50 for receiving the light from the light emitters 22a and light from fluorescing particles via the flow stream 50. The output signals from the light detectors 24a and 24b are provided to controller or processor 40, wherein they are analyzed to identify and/or count selected white blood cells in the core stream 160.
The array 22a of light sources is preferably an array of lasers such as vertical cavity surface emitting lasers (VCSELs) fabricated on a common substrate. Because of their vertical emission, VCSELs are ideally suited for packaging in compact instruments such as a miniaturized portable cytometer. Such cytometer may be wearable on a person's body. Preferably, the VCSELs are “red” VCSELs that operate at wavelengths that are less than the conventional 850 nm, and more preferably in the 670 nm to 780 nm range. Red VCSELs may have a wavelength, power and polarization characteristic that is ideally suited for scatter measurements.
Some prior art cytometer bench models use a single 9 mW edge-emitting laser with a wavelength of 650 nm. The beam is focussed to a 10×100 micron elongated shape to cover the uncertainty in particle position due to misalignment and width of the core stream. In contrast, the output power of the red VCSELs of the present invention, operating at 670 nm, is typically around 1 mW for a 10×10 micron emitter and 100-micron spacing. Thus, the total intensity of the light from a linear array of ten red VCSELs may be essentially the same as that of some prior art bench models.
Using a linear array of lasers oriented at an angle with respect to the flow axis 202 offers a number of important advantages over the single light source configuration of the prior art. For example, a linear array of lasers may be used to determining the lateral alignment of the path of the particles in the core steam. One source of uncertainty in the alignment of the particle stream is the width of the core flow, which leads to statistical fluctuations in the particle path position. These fluctuations can be determined from analysis of the detector data and can be used by the controller or processor 40 to adjust the valves of the fluid driver in order to change the relative pressures that are applied to the sample fluid and the supporting fluids to change the alignment of the selected particles in the flow stream.
To determine the lateral alignment of the cells in the fluid stream 50, the cells pass through several focussed spots produced by the linear array of VCSELs. The cells produce a drop in signal in the corresponding in-line reference detectors. The relative strengths of the signals are used by the controller or processor 40 to determine the center of the particle path and a measure of the particle width.
For determining particle path and size, the lasers 22a are preferably focussed to a series of Gaussian spots 214 (intensity on the order of 1000 W/cm2) in the plane of the core flow. The spots 214 are preferably about the same size as a white blood cell (10-12 um). Illustrative Gaussian spots 214 are shown in
Another advantage of using a linear array 22a of lasers rather than a single laser configuration is that the velocity of each cell may be determined. Particle velocity can be an important parameter in estimating the particle size from light scatter signals. In conventional cytometry, the particle velocity is extrapolated from the pump flow rates. A limitation of this approach is that the pumps must be very precise, the tolerance of the cytometer flow chambers must be tightly controlled, no fluid failures such as leaks can occur, and no obstructions such as microbubbles can be introduced to disturb the flow or core formation.
To determine the velocity of each cell, the system may measure the time required for each cell to pass between two adjacent or successive spots. For example, and with reference to
It is contemplated that the particle velocity can also be used to help control the fluid driver. To reduce the size, cost and complexity of the present invention, the replaceable cartridge of
To further evaluate the cell size, it is contemplated that laser beams may be focused both along the cell path and across the cell path. Additionally, multiple samples across the cell may be analyzed for texture features, to correlate morphological features to other cell types. This may provide multiple parameters about cell size that may help separate cell types from one another.
Another advantage of using a linear array 22a of lasers rather than a single layer configuration is that a relatively constant light illumination may be provided across the flow channel. This is accomplished by overlapping the Gaussian beams 214 from adjacent VCSELs 22a, as shown in
To perform the above described measurements, each detector 24a in
Referring specifically to
A second array of light sources and light detectors is shown at 310. The light sources are arranged in a linear array along a second light source axis that is rotated relative to the flow axis of the flow stream. The light detectors include three linear arrays of light detectors. One array of light detectors is positioned in line with the linear array of light sources. The other two linear arrays of light detectors are placed on either side of the in-line array of light detectors, and are used for measuring the small angle scattering (SALS) produced by selected particles in the flow stream.
The in-line detector 326 may be used to detect the light that is not significantly scattered by the particles in the core stream. Thus, the in-line linear array of light detectors of the second array 302 may be used to provide the same measurements as the in-line array of detectors of the first array 300. The measurements of both in-line arrays of detectors may be compared or combined to provide a more accurate result. Alternatively, or in addition, the in-line detectors of the second array 302 may be used as a redundant set of detectors to improve the reliability of the cytometer.
It is contemplated that the in-line detectors of the second array 302 may also be used in conjunction with the in-line detectors of the first array 300 to more accurately determine the time-of-flight or velocity of the particles in the flow stream. The measurement may be more accurate because the distance between detectors may be greater. As indicated above, by knowing the velocity of the particles, small variations in the flow rate caused by the fluid driver can be minimized or removed by the controller.
Light detectors 328 and 330 of
Referring back to
The annular shaped detector 368 is preferably sized to intercept and detect the forward angle scattering (FALS) produced by selected particles in the flow stream. A non-sensitive region or a separate in-line detector 370 may be provided in the middle of the annular shaped detector 368. If a separate in-line detector 370 is provided, it can be used to provide the same measurement as the in-line detectors of the first array 300 and/or second array 302. When so provided, the measurements from all three in-line arrays of detectors of first array 300, second array 302 and third array 350 may be compared or combined to provide an even more accurate result. The in-line detectors of the third array 302 may also be used as another level or redundancy to improve the reliability of the cytometer.
It is contemplated that the in-line detectors of the third array 350 may also be used in conjunction with the in-line detectors if the first array 300 and/or second array 302 to more accurately determine the time-of-flight or velocity of the particles in the flow stream. The measurement may be more accurate because the distance between detectors may be greater. As indicated above, by knowing the velocity of the particles, small variations in the flow rate caused by the fluid driver can be minimized or removed by the controller.
By using three separate arrays of light sources and detectors, the optics associated with each array can be optimized for the desired application. As can be seen, the optics associated with the first array 300 are designed to provide well-focussed laser light on the plane of the core flow. This helps provide resolution to the alignment, size and particle velocity measurements performed by the first array 300. Likewise, the optics associated with the second array 302 are designed to provide well-focussed laser light on the plane of the core flow. Well focussed light is desirable when measuring the small angle scattering (SALS) produced by selected particles in the flow stream. Finally, the optics associated with the third array 350 are designed to provide collimated light to the core flow. As indicated above, collimated light is desirable when measuring forward angle scattering (FALS) produced by selected particles in the flow stream.
As indicated above, the user may obtain a removable cartridge and provide a blood sample to the sample collector port 32 (see
Rather than obtaining the blood sample by a finger prick or the like, it is contemplated that a catheter 404 or the like may be inserted into a vein of the user and attached to the sample collector port 32. This may allow the system to automatically collect a blood sample from the user whenever a reading is desired. Alternatively, it is contemplated that the miniaturized portable cytometer may be implanted in the user, with the sample collector port 32 connected to a suitable blood supply.
A pump 81 may pump air into a pressure chamber 70. Pump 81 may be a mesopump as described as an illustrative example by U.S. Pat. No. 5,836,750. Pump 81 may be controlled by processor 40 via a line 89 and connection block 87. The air may enter a controlled pressure chamber 72 via a valve 74. The air in chamber 72 may be controlled to be at some pre-determined pressure with mesovalves or other microvalves 74 and 76. The air may proceed into blood reservoir 62. Valve 74 may open and valve 76 may close when more air pressure is needed in chamber 72. Valve 74 may close and valve 76 may open if there is a need to reduce the air pressure in chamber 72. Valves 74 and 76 may be controlled by processor 40 via line 91 and connection block 60. Block 60 represents appropriate connections from line 91 to the valves of chamber 72. The air may proceed through a porous filter 61 on to a blood reservoir 62. Filter 61 may permit a passage of air but blocks the passage of liquid. The air may exert a controlled pressure on the liquid blood in the reservoir 62. The blood may flow from the reservoir 62 through flow sensor 80. Flow sensor 80 may provide information relating to the amount of blood flowing through the sensor via a connection block 48 and line 93 to processor 40. With the sensed blood flow information, processor 40 may send control signals to valves 74 and 76 to control the air pressure upon the liquid in the reservoir 62 so as to result in a predetermined flow rate of the blood into a flow mechanism 88 which may have a flow channel and hydrodynamic focusing.
In a similar fashion as for the blood provision, the lyse provision may have a pump 83 that pumps air into a pressure chamber 71. Pump 83 may be like pump 81. Pump 83 may be controlled by processor 40 via the line 89 and connection block 87. The air may enter a controlled pressure chamber 75. The air in chamber 75 may be controlled to be at some predetermined pressure with valves 84 and 86. The air may proceed on through a porous filter 63 to a lyse reservoir 64. Valve 84 may open and valve 86 may close when more air pressure is needed in chamber 75. Valve 84 may close and valve 86 may open if there is a need to reduce air pressure in chamber 75. Valves 84 and 86 may be controlled by processor 40 via line 91 and connection block 60. Block 60 represents an appropriate connection from line 91 to the valves of chamber 75. The air may proceed through a porous filter 63 on to a lyse reservoir 64. Filter 63 may permit a passage of air but block the passage of liquid. The air may exert a controlled pressure on the liquid lyse in the reservoir 64. The lyse may flow from the reservoir through flow sensor 100. Flow sensor 100 may provide information about the amount of lyse flowing through the sensor via a connecting block 48 and line 93 to processor 40. With the sensed lyse flow information, processor 40 may send control signals to valves 84 and 86 to control the air pressure upon the liquid in the reservoir 64 so as to result in a predetermined flow rate of the lyse into a flow focusing mechanism 88.
In a similar fashion, as for the blood and lyse provisions, the sheath provision may have a pump 85 that pumps air into a pressure chamber 73. Pump 85 may be a pump like pumps 81 and 83. Pump 85 may be controlled by processor 40 via the line 89 and connection block 87. The air may enter from chamber 73 to a controlled pressure chamber 77. The air in chamber 77 may be controlled to be at some predetermined pressure with valves 94 and 96. The air may proceed from chamber 77 through a porous filter 65 on to a sheath reservoir 66. Valve 94 may open and valve 96 may close when more air pressure is needed in chamber 77. Valve 94 may close and valve 96 may open if there is a need to reduce air pressure in chamber 77. Valves 94 and 96 may be controlled by processor 40 via line 91 and connection block 60. Block 60 represents an appropriate connection from line 91 to the valves of chamber 77. The air may exert a controlled pressure on the liquid sheath in the reservoir 66. The sheath may flow from the reservoir through flow sensor 102. Flow sensor 102 may provide information about the amount of sheath flowing through the sensor 102 via a connecting block 48 and line 93 to processor 40. With the sensed sheath flow information, processor may send signals to pump 85 and valves 94 and 96 to control the air pressure upon the sheath liquid in the reservoir 66 so as to result in a predetermined flow rate of the sheath into the flow mechanism 88. Ports, connected to an external pressurized air supply, may be implemented in lieu of pumps 81, 83 and 85 on cartridge 14 in
In the flow mechanism 88, the blood from reservoir 62 may be lysed of its red blood cells and inserted with a flow channel (50) with a sheath liquid around the stream of the white cells (remaining) in the blood into a single file. The white cells and other particles may be illuminated by light sources, and light from the flow channel may be detected by detectors. The light sources and detectors may be controlled and information may be had from them via connections on line 97 between processor 40 and mechanism 88. Mechanism 88 and the flow channel are described in other places of the present description. After the blood sample along with the sheath leave the flow channel of mechanism, it may go into the waste reservoir 52.
Before the cartridge 14 is used and until its system is pressurized, a set of downstream valves 110 between reservoirs 62, 64 and 66 and mechanism 88 may be closed. Their closure and open status may be controlled by processor 40 via line 95 and connection block 110.
A blood sample may be entered into the blood reservoir 62 via port 32. A pump 81 may pump blood from reservoir 62 through a flow sensor 80 into the flow mechanism 88. Flow sensor 80 provides a signal indicating a rate of flow of the blood via connection block 48 and line 93 to processor 40. Processor 40 may control the amount of flow through sensor 80 by a control signal to pump 81 via line 89 and connection block 87.
Lysing liquid in the lyse reservoir 64 may be pumped through flow sensor 100 by a pump 83. Flow sensor 100 may sent a signal to processor 40, indicating a rate of flow of the lyse through the sensor into the flow mechanism 88. This signal may go to processor 40 via the connection block 48 and line 93. Processor 40 may adjust the rate of flow of the lyse through sensor 100 with a signal sent to pump 83 via line 89 and connection block 87.
Sheath fluid may be pumped by pump 85 from the sheath reservoir 66 through a flow sensor 102 on into the flow mechanism 88. Flow sensor 102 may send a signal indicating the amount of flow of the sheath liquid passing through the sensor 102. This signal may go to processor 40 via the connection block 48 and line 93. Processor 40 may adjust the amount or rate of flow of the sheath liquid through sensor 102 and into mechanism 88 with a signal sent to pump 85 via the line 89 and connection block 87.
The sample blood may enter mechanism 88 and be lysed with the fluid pumped from reservoir 64 through sensor 100 to remove the red blood cells. The lysed blood may go through a flow channel (50) with a sheath liquid around the blood causing the white cells in the blood to go through the flow channel in single file. The white cells and other particles may be illuminated with light from the light sources. Light from the flow channel may be detected by detectors. The light sources may be controlled by processor 40 via line 97 to mechanism 88. The detectors may provide information signals to processor 40 via line 97. Flow mechanism 88 and the flow channel with its optics are described in other places of the present description. After the blood sample along with the sheath liquid leave the flow channel of the mechanism, it may go into the waste reservoir 52.
During storage, a removable cap 114 may be attached to the microfluidic circuit of chip 14. Lyse may be stored on board in reservoir 64. Valves 115 and 116 may be open. Valves 117, 118, 119 and 121 may be closed. One may do an analysis or test on cartridge 14.
Cap 114 may be removed and a drop of blood may put into the sample inlet 32. Capillary action may draw the blood into the sample storage sub-circuit. The cap 114 may be snapped on to the sample inlet 32 and the cartridge 14 may be placed into the cytometer case or bench apparatus.
By closing the cover of the chip, card or cartridge 14 holder, valves 115 and 116 may close and valves 117, 118, 119 and 121 may open as in
The particles or cells in flow channel 50 may pass by the light source and detector system 136. Small angle scattering (SALS), forward angle scattering (FALS) and large angle scattering (LALS) caused by the particles in the flow stream may be detected. Arrays of light sources and detectors may be used. Also, interruptions of direct light may be detected. Particle width, length, center and velocity may be determined. Various other properties and identification information of the particles may be obtained with the optical system.
A previous cytometer system used so-called volume-controlled flow, generated by miniature syringe pumps driven with stepper motors or manually, to drive all reagents and the sample through the microfluidic circuit of cartridge 14. The system may be precise but is extremely bulky and uses significant electrical power. In order to miniaturize and make energy efficient the fluid driving system, the open-loop, very precise and stable but bulky and expensive fluid driving elements may be replaced with less precise and less stable pressure sources which can be adjusted in a closed loop configuration to maintain a constant, desired flow velocity at critical points of the fluidic circuit. Implementation of this approach may rely on small and sensitive fluid flow sensors for measurement of flow rates as low as 10 nanoliters per second in sub-millimeter channels, and fast and small actuators for closed loop, pressure control.
There may be a manually pressurized system described in other places of this description. Another approach may involve active pumping accomplished with mesopump channels.
Mesopumps 137 may be, for an example, dual diaphragm pumps which are in principle described in U.S. Pat. No. 6,179,586 B1, issued Jan. 30, 2001, which is incorporated herein by reference. Also, information related to mesopumps and valves may be disclosed in U.S. Pat. No. 5,836,750, issued Nov. 17, 1998, which is incorporated herein by reference. U.S. Pat. Nos. 6,179,586 B1 and 5,836,750 are owned by the entity that owns the present invention.
In
The flow of fluid in the configuration of
The configurations of
Although the some of the components discussed in
Liquid flow sensor 163 may be embedded or built into the cartridge 14 or it may be removed from the cartridge which may be disposed of after usage, and reused in another cartridge 14. Liquid flow sensor 163 may be may be removable from a slot or holder in one cartridge 14 for reusability in another cartridge with a similar slot or holder. The same may apply to the gas flow sensor 164. The various off-cartridge components may be connected to the components on the cartridge 14 via appropriate plumbing.
Even though the
In the present specification, some of the matter may be of a hypothetical or prophetic nature although stated in another manner or tense.
Although the invention has been described with respect to at least one illustrative example, many variations and modifications will become apparent to those skilled in the art upon reading the present specification. It is therefore the intention that the appended claims be interpreted as broadly as possible in view of the prior art to include all such variations and modifications.
Claims
1. A flow control system comprising:
- a fluidic cartridge having at least one flow channel;
- an electrostatically actuated valve situated in at least one flow channel of the cartridge, wherein the electrostatically actuated valve includes a valve cavity with a movable diaphragm within the valve cavity, wherein the movable diaphragm is actuated by an electrostatic force to open the electrostatically actuated valve to allow flow through the at least one flow channel and/or close the electrostatically actuated valve to prevent flow through the at least one flow channel;
- a controller connected to the electrostatically actuated valve for controlling the opening and/or closing of the electrostatically actuated valve during operation of the fluidic cartridge; and
- a flow sensor in fluid communication with the at least one flow channel the flow sensor measuring the velocity of fluid flow, and the controller controlling the valve to achieve a desired fluid velocity in the at least one flow channel.
2. The system of claim 1, wherein the electrostatically actuated valve is a mesovalve.
3. A flow control system comprising:
- a fluidic cartridge having at least one flow channel;
- a pump situated in the cartridge, the pump in fluid communication with at least one flow channel of the cartridge;
- a controller connected to the pump; and
- a flow sensor situated in the cartridge and in fluid communication with the at least one flow channel of the cartridge, the flow sensor providing a flow signal representing the fluid velocity to the controller, and the controller controlling the pump to achieve a desired flow profile in the at least one flow channel of the cartridge.
4. The system of claim 3, wherein the pump is a bidirectional pump.
5. (canceled)
6. The system of claim 3, wherein:
- the pump is a liquid pump; and
- the flow sensor is a liquid flow sensor.
7. The system of claim 3, wherein the pump is gas pump.
8. The system of claim 7, wherein the pump is an electrostatically actuated gas pump.
9. The system of claim 8, further comprising a reservoir fluidly connected to gas pump.
10. The system of claim 9, wherein the flow sensor is fluidly connected to the reservoir and electrically connected to the controller.
11. The system of claim 3, further comprising:
- a buffer fluidly connected to the pump; and
- a reservoir fluidly connected to the buffer.
12. The system of claim 11, wherein the flow sensor is fluidly connected to the reservoir.
13. The system of claim 12, wherein:
- the pump is a gas pump; and
- the reservoir is a liquid reservoir.
14. The system of claim 3, further comprising:
- a pressure chamber fluidly connected to the pump; and
- a reservoir fluidly connected to the pressure chamber.
15. The system of claim 14, wherein the pressure chamber comprises:
- an inlet valve connected to the controller; and
- a relief valve.
16. The system of claim 15, wherein:
- the pump is an electrostatically actuated pump; and
- the valves are electrostatically actuated valves.
17. The system of claim 15, wherein the flow sensor is fluidly connected to the reservoir and electrically connected to the controller.
18. The system of claim 3, further comprising:
- a pressure chamber fluidly connected to the pump; and
- a liquid reservoir fluidly connected to the pressure chamber.
19. The system of claim 18, wherein the fluidic cartridge has a thickness of less than 10 mm and an area less than 150 cm2.
20. The system of claim 18, wherein the pressure chamber comprises:
- an inlet valve connected to the controller; and
- a pressure sensor connected to the controller.
21. The system of claim 20, wherein the flow sensor is fluidly connected to the reservoir and electrically connected to the controller.
22. The system of claim 21, further comprising a buffer fluidly connected between the pump and the pressure chamber.
23. The system of claim 22, wherein:
- the pump is a gas pump; and
- the reservoir is a liquid reservoir.
24. The system of claim 23, wherein:
- the pump is an electrostatically actuated pump; and
- the valve is an electrostatically actuated valve.
25. The system of claim 21, wherein the flow sensor is situated off of the cartridge.
Type: Application
Filed: Apr 25, 2005
Publication Date: Aug 14, 2008
Applicant: HONEYWELL INTERNATIONAL INC. (Morristown, NJ)
Inventors: Cleopatra Cabuz (Eden Prairie, MN), Eugen Cabuz (Eden Prairie, MN)
Application Number: 10/908,014
International Classification: A61M 37/00 (20060101);